Lineage Cell Therapeutics Community

Key Takeaways Strong data support and partnership expansions, especially for OpRegen, could significantly enhance future revenue and market share in dry AMD. Manufacturing advancements and new partnerships could reduce production costs, improve margins, and provide additional revenue, enhancing financial stability.